MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure
نویسندگان
چکیده
منابع مشابه
MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure.
Endothelial function is impaired by oxidative stress in chronic heart failure (HF). Mechanisms that protect against increases in oxidative stress in HF are not clear. The goal of this study was to determine whether manganese superoxide dismutase (MnSOD) plays a key role in protecting against endothelial dysfunction in HF. Endothelial function and gene expression were examined in aorta from wild...
متن کاملEndothelial dysfunction in heart failure.
Endothelial dysfunction crucially contributes to the development of impaired coronary and systemic perfusion as well as reduced exercise capacity in patients with congestive heart failure, with fundamental impact on morbidity and mortality. Reduced bioavailability of nitric oxide (NO) and abundant formation of reactive oxygen species (ROS) within the vascular wall are the key determinants in en...
متن کاملAllopurinol improves endothelial dysfunction in chronic heart failure.
BACKGROUND Increased oxidative stress in chronic heart failure is thought to contribute to endothelial dysfunction. Xanthine oxidase produces oxidative stress and therefore we examined whether allopurinol improved endothelial dysfunction in chronic heart failure. METHODS AND RESULTS We performed a randomized, placebo-controlled, double-blind crossover study on 11 patients with New York Heart ...
متن کامل[Inflammation and endothelial dysfunction in patients with chronic heart failure].
BACKGROUND In chronic heart failure (CHF), endothelial dysfunction (ED) is a consequence of an imbalance of vascular tone regulating substances. The relationship between ED and inflammation has not been fully investigated. AIM To assess the association between inflammation and ED in CHF. MATERIAL AND METHODS Forty two patients aged 56+/-14 years (80% male) with a CHF in functional capacity ...
متن کاملErythropoietin protects against doxorubicin-induced heart failure.
The hormone erythropoietin (EPO) has been demonstrated to have cardioprotective properties. The present study investigates the role of EPO to prevent heart failure following cancer treatment with doxorubicin [adriamycin (AD)]. Male Wistar rats (150 ± 10 g) were treated with saline (vehicle control group); with EPO, subcutaneously at 1,000 IU/kg body wt, three times per week for 4 wk (EPO group)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Physiology-Heart and Circulatory Physiology
سال: 2010
ISSN: 0363-6135,1522-1539
DOI: 10.1152/ajpheart.01108.2009